Evidence map›Paper›PMID 34467943›Full record

ArticleChemosphere2021

City-level SARS-CoV-2 sewage surveillance.

Karin Yaniv, Marilou Shagan, Yair E Lewis, Esti Kramarsky-Winter, Merav Weil, Victoria Indenbaum, Michal Elul, Oran Erster, Alin Sela Brown, Ella Mendelson and 20 more

Abstract read
In one paragraph

Article in Chemosphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Detergent Virus Inactivation in Chromatography Systems.Biotechnology and bioengineering · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. 20-Month monitoring of SARS-CoV-2 in wastewater of Curitiba, in Southern Brazil.Environmental science and pollution research international · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Calibration of Methods for SARS-CoV-2 Environmental Surveillance: A Case Study from Northwest Tuscany.International journal of environmental research and public health · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Karin YanivAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, PO Box 653, BeerSheva 8410501, Israel.
Marilou ShaganAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, PO Box 653, BeerSheva 8410501, Israel.
Yair E LewisMaccabi Healthcare Services, Israel.
Esti Kramarsky-WinterAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, PO Box 653, BeerSheva 8410501, Israel.
Merav WeilCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Victoria IndenbaumCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Michal ElulCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Oran ErsterCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Alin Sela BrownCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Ella MendelsonCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel; School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Batya MannasseCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Rachel ShiraziCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Satish LakkakulaAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, PO Box 653, BeerSheva 8410501, Israel.
Oren MironDepartment of Health Systems Management, School of Public Health, Faculty of Health Science, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ehud RinottDepartment of Health Systems Management, School of Public Health, Faculty of Health Science, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ricardo Gilead BaibichKANDO, Environment Services Ltd, Tsor St 8, Kokhav Ya'ir Tzur Yigal, Israel.
Iris BiglerKANDO, Environment Services Ltd, Tsor St 8, Kokhav Ya'ir Tzur Yigal, Israel.
Matan MalulKANDO, Environment Services Ltd, Tsor St 8, Kokhav Ya'ir Tzur Yigal, Israel.
Rotem RishtiKANDO, Environment Services Ltd, Tsor St 8, Kokhav Ya'ir Tzur Yigal, Israel.
Asher BrennerDepartment of Civil and Environmental Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Eran FriedlerFaculty of Civ. and Env. Eng., Technion-Israel Inst. of Technology, Haifa, 32000, Israel.
Yael GilboaFaculty of Civ. and Env. Eng., Technion-Israel Inst. of Technology, Haifa, 32000, Israel.
Sara SabachFaculty of Civ. and Env. Eng., Technion-Israel Inst. of Technology, Haifa, 32000, Israel.
Yuval AlfiyaFaculty of Civ. and Env. Eng., Technion-Israel Inst. of Technology, Haifa, 32000, Israel.
Uta CherutiFaculty of Civ. and Env. Eng., Technion-Israel Inst. of Technology, Haifa, 32000, Israel.
Nadav DavidovichDepartment of Health Systems Management, School of Public Health, Faculty of Health Science, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Jacob Moran-GiladDepartment of Health Systems Management, School of Public Health, Faculty of Health Science, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Yakir BerchenkoDepartment of Industrial Engineering and Management, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel.
Itay Bar-OrCentral Virology Lab, Ministry of Health, Sheba Medical Center, Israel.
Ariel KushmaroAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, PO Box 653, BeerSheva 8410501, Israel; The Ilse Katz Center for Meso and Nanoscale Science and Technology, Ben-Gurion University of the Negev, Be'er Sheva, 8410501, Israel. Electronic address: arielkus@bgu.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic created a global crisis impacting not only healthcare systems, but also economics and society. Therefore, it is important to find novel methods for monitoring disease activity. Recent data have indicated that fecal shedding of SARS-CoV-2 is common, and that viral RNA can be detected in wastewater. This suggests that wastewater monitoring is a potentially efficient tool for both epidemiological surveillance, and early warning for SARS-CoV-2 circulation at the population level. In this study we sampled an urban wastewater infrastructure in the city of Ashkelon (̴ 150,000 population), Israel, during the end of the first COVID-19 wave in May 2020 when the number of infections seemed to be waning. We were able to show varying presence of SARS-CoV-2 RNA in wastewater from several locations in the city during two sampling periods, before the resurgence was clinically apparent. This was expressed with a new index, Normalized Viral Load (NVL) which can be used in different area scales to define levels of virus activity such as red (high) or green (no), and to follow morbidity in the population at the tested area. The rise in viral load between the two sampling periods (one week apart) indicated an increase in morbidity that was evident two weeks to a month later in the population. Thus, this methodology may provide an early indication for SARS-CoV-2 infection outbreak in a population before an outbreak is clinically apparent.

Indexed as

COVID-19SewageHumansPandemicsRNA, ViralSARS-CoV-2WastewaterRNA, ViralSewageWastewaterEarly warningNormalized viral loadPopulation monitoringSARS-CoV-2Wastewater epidemiology

Identifiers

PMID34467943
PMCPMC8217074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.